Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New inhibitors of insulin-like growth factor 1 receptor presented

Dec. 29, 2010

AKN-028 significantly alters gene expression profiles of AML cells

Dec. 29, 2010

PI3K-alpha inhibitor PIK-75 induces apoptosis of AML cells

Dec. 29, 2010

EMA to review Allos' MAA for Folotyn in relapsed or refractory PTCL

Dec. 28, 2010

Vertex Pharma patents new inhibitors of hepatocyte growth factor receptor

Dec. 28, 2010

New CREB-1 inhibitor XX-650-23 shows promise to treat AML

Dec. 28, 2010

Enrollment completed in phase II study of belinostat in carcinoma of unknown primary

Dec. 27, 2010

Novartis receives E.U. approval for Tasigna in newly diagnosed Ph+ CML

Dec. 27, 2010

Phase IIb study begins of Azixa as front-line treatment for glioblastoma multiforme

Dec. 27, 2010

Cyclacel's cell cycle inhibitor CYC-065 suppresses growth of MM cell in vitro

Dec. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...